PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice

International Journal of Biological Sciences

Volumn 4, Issue 4, 2008, Pages 236-244

  Rodriguez, Walter E ^a   Sen, Utpal ^a   Tyagi, Neetu ^a   Kumar, Munish ^a   Carneal, Gene ^a   Aggrawal, Deep ^a   Newsome, Justin ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cardiac function; Cardiac rings; Ciglitazone; GFR; Homocysteine; PPAR

Indexed keywords

ALLOXAN; CIGLITAZONE; GLUCOSE; HOMOCYSTEINE; INULIN; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL MOUSE; CARDIOVASCULAR PARAMETERS; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE; HEART VENTRICLE FUNCTION; IN VIVO STUDY; MALE; MILLAR CATHETER; MOUSE; MUSCLE CELL; NONHUMAN; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG POTENTIATION; ENDOTHELIUM; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY;

MUS;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, INBRED C57BL; MUSCLE CELLS; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 49749148712     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4.236     Document Type: Article

References (28)

1. Hoppeler H, Kayar SR. Capillary and oxidative capacity of muscles. News in Physiol Sci. 1988; 3:113-6.
2. Roberts JT, Wearn JT. Quantitative changes in the capillary-muscle relationship in human hearts during normal growth and hypertrophy. Am Heart J. 1941;15:617-33.
3. Pinsky DJ, Patton S, Mesaros S et al. Mechanical Transduction of NO synthesis in the beating heart. Circ Res. 1997; 81:372-9.
4. Wang J, Morgan JP. EE modulates myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium. Cir Res. 1992;70:754-60.
5. Gattuso A, Mazza R, Pellegrino D, Tota B. Endocardial endothelium (EE) mediates luminal acetylcholine-nitric oxide signaling in isolated frog heart. Am J Physiol. 1999; 276:H633-41.
6. Tyagi SC, Smiley LM, Mujumdar VS. Homocyst(e)ine impairs endocardial endothelial function. Canad J Physiol & Pharmacol. 1999;77:950-7.
7. Shah AM, Grocott-Mason RM, Pepper CB et al. The cardiac endothelium: cardioactive mediators. Prog Cardiovasc Dis. 1996; 39:263-8.
8. Rodriguez WE, Tyagi N, Joshua IG, Passmore JC, Fleming JT, Falcone JC, Tyagi SC. Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus. Am J Physiol Renal Physiol. 2006; 291:F694-701.
9. Finkelstein JD. Methionine metabolism in mammals. J Nutr Biochem. 1990; 1:228-37.
10. Pouwels MJ, den Heijer M, Blom HJ, Tack CJ, Hermus AR. Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine. Diabetes Care. 2003; 26:1637-9.
11. Shukia N, Thompson CS, Angelini GD, Mikhailidis DP, Jeremy JY. Homocysteine enhances impairment of endothelium-dependent relaxation and cGMP formation in aortae from diabetic rabbits. Diabetologia. 2002; 45:1325-31.
12. Wollesen F, Brattstrom L, Refsum H, Ueland PM, Bergiund L, Beme C. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int. 1999; 55:1028-35.
13. Fukagawa NK, Minaker KU, Young VR, Rowe JW. Insulin dose-dependent reductions in plasma amino acids in man. Am J Physiol. 1986; 250:E13-7.
14. Hulin B, McCarthy PA, Gibbs E M. The glitazone family of antidiabetic agents. Curr Pharm Des. 1996; 2: 85-102.
15. Papaioannou VE, Fox JG. Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci. 1993; 43:189-92.
16. Nolte RT, Wisely GB, Westin S et al. Ligand binding and co-activator assembly of the PPARγ. Nature. 1998; 395:137-43.
17. Evans M, Anderson RA, Graham J et al. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. Circulation. 2000; 101:1773-9.
18. Scatena R, Bottoni P, Martorana GE et al. Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology. Eur J Pharmacol. 2007; 567:50-8.
19. Qi Z, Whitt I, Mehta A et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol. 2004; 286:F590-6.
20. Tarone RE. A modified Bonferroni method for discrete data. Biometrics. 1990; 46:515.
21. Pieper GM. Enhanced, unaltered and impaired NO-mediated endothelial-dependent relaxation in experimental diabetes: importance of disease duration. Diabetologia. 1999; 42:204-13.
22. Baykan M, Erdogan T, Erem C, Hacihasanoglu A, Gedikli O, Küçükosmanoglu M, Celik S, Orem C. The relationship between flow-mediated dilatation and left ventricular function in type 2 diabetic patients with microalbuminuria. Endocrine. 2006; 30:197-202.
23. Duncan ER, Walker SJ, Ezzat VA, Wheatcroft SB, Li JM, Shah AM, Kearney MT. Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species. Am J Physiol Endocrinol Metab. 2007; 293: E1311-9.
24. Malakul W, Thirawarapan S, Suvitayavat W, Woodman OL. Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta. Clin Exp Physiol. 2008; 35:192-200.
25. Camp T, Smiley L, Hayden MR, Tyagi SC. Mechanism accumulation and glomerulosclerosis in spontaneously hypertensive rats. J Hyperten. 2003; 21:1719-27.
26. Papatheodorou L, Weiss N. Vascular oxidant stress inflammation in hyperhomocysteinemia. Antioxid Redox 2007; 9:1941-58.
27. Pfützner A, Weber MM, Forst T. Pioglitazone: update antidiabetic drug with antiatherosclerotic effects. Expert Pharmacother. 2007; 8:1985-98.
28. Tyagi N, Moshal KS, Sen U, Lominadze D, Ovechkin SC. Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation endothelial cells by inducing peroxisome proliferator receptor-gamma activity. Cell Mol Biol. 2006; 52:21-7.